GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75F40121C00167EMBLEEMA INC

Overview

Award facts

Net obligations
$9.75M
$9,751,139of $9.75M potential value
Outlays (paid to date)
$9.75M
$9.75M paid of $9.75M obligated$9,749,586
Period of performance
Sep 13, 2021 to Sep 16, 2025
Ended
Modifications
7
Latest action Sep 10, 2025
Contract type
Definitive contract
PIID 75F40121C00167

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

DEVELOPMENT AND MAINTENANCE OF FDA-ARGOS 2 CONTAINING REGULATORY GRADE REFERENCE GENOMES FOR DIAGNOSTIC USE AND REGULATORY SCIENCE

Dates and value

Award date
Signed on Sep 13, 2021
Potential end of performance
Sep 15, 2025
Current value
$9,751,139Base and exercised options
Potential value (if all options are exercised)
$9,751,139

Obligations by fiscal year of action

  • FY2025: $835,000
  • FY2024: $1,996,916
  • FY2023: $1,500,000
  • FY2022: $3,427,000
  • FY2021: $1,992,223

Total across 5 fiscal years: $9,751,139

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 10, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationMETUCHEN, NJ
UEIPQGTDJ2DF644
CAGE code8KW01
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyEMBLEEMA INC

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Foods; Human drugs; Devices and radiological health; Fda other activities (fda headquaters); Animal drugs and feed; Biologics; Coronavirus emergency funding supplemental; Fda reimbursable program (federal sources)Program activities075-0600Federal accounts (agency financial reports)

Place of performance

Place of performance
Silver Spring, Montgomery County, Maryland 20993-0001
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Basic researchBR
Set-aside
No set-aside used
Contract pricing
Cost no feeS
Offers received
10

Solicitation and notices

Solicitation ID
FDABAA-21-00123
Solicitation date
Nov 20, 2020
Notices

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Yes - CAS clause includedY
Certified cost or pricing data
No
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
Yes - service where PBA is used.Y

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 13, 2021Base obligation at award: $1,992,223
Latest action
Sep 10, 2025 — Supplemental agreement (within scope)Modification P00007; obligation change +$835,000
Latest substantive action
Sep 10, 2025 — Supplemental agreement (within scope)Modification P00007; obligation change +$835,000
Actions by type
  • Base award1
  • Other administrative action4
  • Supplemental agreement (within scope)2
  • Option exercised1
8 actions recorded, Sep 13, 2021 to Sep 10, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
$835,000
Latest action: change in base and all options
$835,000

Socio-economic and policy

Inherently governmental functions
Closely associatedCL
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
8

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2021/2021-0600-000
  • 075-2022/2022-0600-000
  • 075-2023/2023-0600-000
  • 075-2024/2024-0600-000
  • 075-X-0600-000
Object classes
  • 25.1: Advisory and assistance services
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • L: Emergency P.L. 116-123
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
COVID-19 supplemental obligations
$97,223
COVID-19 supplemental outlays
$97,210